The results announced today from the fifth cohort of the RESOLVE trial, for treatment of EoE, are derived from 12, 4 mg injections of EP-104GI (total dose of 48 mg) administered to the lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback